Xyntha

Entity type image
Type: Product
Name: Xyntha
First reported May 21 2013 - Updated May 21 2013 - 1 reports
NOVO NORDISK A/S
NOVO NORDISK A/S

Positive Data on Novo Nordisk's N9-GP

Novo Nordisk (NVO) recently announced positive phase III data on its hemophilia B candidate, N9-GP, from the paradigm 2 study.Paradigm 2 evaluated N9-GP, a long-acting FIX derivative, for on-demand or prophylactic treatment of hemophilia B patients. Results ... [Published Yahoo! Finance - May 21 2013]

More Content

All (1) | News (1) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Positive Data on Novo Nordisk's N9-GP [Published Yahoo! Finance - May 21 2013]
1
In Focus
Content Volume
Document Volume
Network
Network
About
Silobreaker
Press Room
Products
Online Service
On-Premises Software
Contact Us
Sales
Support
Legal
Terms of Use
Privacy Policy


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.